Non-Current Assets

Indefinite-Lived Research and Development Assets

International Business Machines Indefinite-Lived Research and Development Assets increased by 5.8% to $4.43B in Q4 2025 compared to the prior quarter. Over 3 years (FY 2022 to FY 2025), Indefinite-Lived Research and Development Assets shows an upward trend with a 13.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ4 2021
Last reportedQ4 2025

How to read this metric

An increase indicates active investment in future technology, while a decrease may signal project completion or impairment.

Detailed definition

These are acquired in-process research and development (IPR&D) projects that have not yet reached technological feasibil...

Peer comparison

Common in technology and pharmaceutical sectors following M&A activity.

Metric ID: indefinite_lived_rd_assets

Historical Data

4 periods
 Q4 '22Q4 '23Q4 '24Q4 '25
Value$3.01B$3.52B$4.19B$4.43B
QoQ Change—+17.0%+18.8%+5.8%
YoY Change—+17.0%+18.8%+5.8%
Range$3.01B – $4.43B
Avg YoY Growth+13.8%
Median YoY Growth+17.0%
Current Streak3+ quarters growth

Frequently Asked Questions

What is International Business Machines's indefinite-lived research and development assets?
International Business Machines (IBM) reported indefinite-lived research and development assets of $4.43B in Q4 2025.
What is the long-term trend for International Business Machines's indefinite-lived research and development assets?
Over 3 years (2022 to 2025), International Business Machines's indefinite-lived research and development assets has grown at a 13.7% compound annual growth rate (CAGR), from $3.01B to $4.43B.
What does indefinite-lived research and development assets mean?
The value of research projects acquired from other companies that are still in progress.